Abstract:Objective. To analyse the resistance of 280 clinical isolates from patients with nosocomial infection to 7 β-lactams [cefoperazone (CPZ), ceftazidime (CAZ), imipenem (IPM), ceftriaxone (CRO), cefotaxime (CTX), aztreonam (AZ) and cefoperazone/sulbactam (CPZ/SB)]. Methods. MICs of 7 β- lactams against clinical isolates were detected by the method of MH-broth dilution, β-lactamases were detected by hydrolysis of penicillin G and nitrocefin. Result. (1) All of the 7 β-lactams demonstrated high resistance to isolates of Staphylococci and Enterococci, except for imipenem to enterococci (with resistant rates of 21.0%). (2) To most of gram-negative microorganisms, imipenem showed quite low resistant rate (0~18.1% to E. coli, K. pneumoniae, Enterobacter cloacae, Acinetobacter and P. aeruginosa), but highly resistant to X. maltophillia (95.5%), gram-negative microorganisms isolates showed higher resistant to another 6 β-lactams. Conclusion. The resistant rates of IPM, CPZ/SB and CAZ are the lowest. The β-lactamase producing strains of the gram-negative isolates are cross-resistant to AZ with the other third generation cephalosporins and it has no activity against gram-positive cocci.

Comparison of antimicrobial activity in vitro of 7 β-lactams against 280 isolates from patients with nosocomial infections